About Charles Henry, MD
Dr. Henry is a child, adolescent, and adult psychiatrist who specializes in the treatment of patients with developmental disorders. After completing his training in 2001 at the Cambridge Hospital Child Fellowship Program, he joined the faculty at MGH and HMS.
Over the last ten years, Dr. Henry conducted research and provided clinical care for children with autism. He is frequently consulted on the psychopharmacologic treatment of these patients and has participated nationally in the development of evidence-based guidelines for the management of symptoms associated with autism.
Dr. Henry provides services at the MGH Child Psychiatry Outpatient Clinic where he supervises residents emphasizing both psychopharmacologic and psychodynamic perspectives with a particular emphasis on the understanding of parental limit setting failures in children with disruptive behavior disorders.
Clinical Interests:
- Autism spectrum disorders
Treats:
- Adult & Pediatrics
Locations
Mass General Psychiatry
55 Fruit St.
Boston, MA 02114
Phone: 617-724-5600
Medical Education
- MD, Northwestern University Medical School
- Residency, Beth Israel Deaconess Hospital
- Residency, Boston Children's Hospital
- Residency, Brigham and Women's Hospital
- Residency, North Suffolk Mental Health Association
- Residency, Shriners Burn Hospital
- Fellowship, Cambridge Health Alliance
American Board Certifications
- Child and Adolescent Psychiatry, American Board of Psychiatry and Neurology
- Psychiatry, American Board of Psychiatry and Neurology
Accepted Insurance Plans
- Medicare
- Medicare ACO
- Railroad Medicare
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
In addition to providing clinical care, administrative oversight, and teaching, Dr. Henry has conducted clinical research on the psychopharmacology of autism. He has received funding from the Casa Colina Foundation that has supported investigations on the effectiveness of serotonin reuptake inhibitors in autistic children. He has also participated in multicenter clinical trials investigating the effects of aripiprazole on irritability in these patients. During his child fellowship, Dr. Henry was granted a Livingston Award through HMS to examine self-awareness and neurocognitive measures in schizophrenic patients being treated with olanzapine. Research funding has resulted in multiple first-author publications and abstract presentations.